A non-mosaic transchromosomic mouse model of Down syndrome carrying the long arm of human chromosome 21

Yasuhiro Kazuki, Feng Gao, Yicong Li, Anna J. Moyer, Benjamin Devenney, Kei Hiramatsu, Sachiko Miyagawa‐Tomita, Satoshi Abe, Kanako Kazuki, Naoyo Kajitani, Narumi Uno, Shoko Takehara, Masato Takiguchi, Miho Yamakawa, Atsushi Hasegawa, Ritsuko Shimizu, Satoko Matsukura, Naohiro Noda, Narumi Ogonuki, Kimiko Inoue, Shogo Matoba, Atsuo Ogura, Liliana Florea, Alena Savonenko, Mei-Fang Xiao, Dan Wu, Denise Batista, Junhua Yang, Zhaozhu Qiu, Nandini Singh, Joan T. Richtsmeier, Takashi Takeuchi, Mitsuo Oshimura, Roger H. ReeveseLife 2020 · DOI

TL;DR

Researchers have developed a new, non-mosaic mouse model of Down syndrome (DS) called TcMAC21, which carries a mouse artificial chromosome containing the entire long arm of human chromosome 21 (HSA21q). This model is more complete and reliable than previous DS mouse models, offering a powerful new tool for understanding DS and testing potential treatments.

What Problem Does This Paper Address?

Down syndrome (DS) is caused by trisomy of human chromosome 21 (HSA21). While animal models are crucial for studying DS, existing models have limitations. The most advanced transchromosomic (Tc) mouse model, Tc1, carries a human chromosome 21 but is mosaic, meaning not all cells in the mouse have the extra chromosome. This mosaicism complicates research by introducing variability and making it harder to interpret results. Furthermore, the Tc1 model has disruptions to over 50 protein-coding genes (PCGs) on HSA21. The authors aimed to create a more accurate and less variable genetic model of DS by developing a mouse that carries a complete, non-mosaic HSA21q on a mouse artificial chromosome (MAC).

Methods

The core of this research involved sophisticated chromosome engineering techniques. The authors utilized a mouse artificial chromosome (MAC) vector, which is capable of carrying large genomic segments. They constructed a HSA21q-MAC by:

  1. Creating a HSA21-loxP chromosome: A specific site (loxP) was inserted into a human chromosome 21 (Chr.21) in DT40 cells.
  2. Microcell-mediated chromosome transfer (MMCT): The modified HSA21-loxP chromosome was transferred into Chinese hamster ovary (CHO) cells that already contained the MAC1 vector.
  3. Reciprocal translocation: A Cre-loxP recombination system was used to induce a targeted translocation between the MAC1 vector and the HSA21-loxP chromosome, resulting in the HSA21q-MAC.
  4. ES cell transfer: The HSA21q-MAC was then transferred into mouse embryonic stem (ES) cells.
  5. Chimeric mouse generation: These ES cells were used to create chimeric mice, and subsequently, a stable mouse line (TcMAC21) was established through breeding.

Whole genome sequencing (WGS) was performed to confirm the integrity and content of the HSA21q-MAC. RNA-Seq was used to analyze gene expression patterns of HSA21 genes and their mouse orthologs. Various phenotypic analyses, including histology, MRI, micro-CT scans, and behavioral tests, were conducted to assess DS-like characteristics.

Datasets

The study utilized existing datasets for comparative analysis and generated new data through their experiments.

  • Whole Genome Sequencing (WGS): Data was generated from TcMAC21 mice and mapped to both mouse and human reference genomes.
  • RNA-Sequencing (RNA-Seq): Transcriptome data was generated from TcMAC21 and euploid (Eu) mouse brains to compare gene expression.
  • Phenotypic Data: Datasets were collected from various analyses including heart morphology, brain MRI, craniofacial micro-CT scans, peripheral blood counts, colony-forming assays, radiosensitivity tests, and behavioral tests (nesting, open field, water maze, RRWM, LTP).

Key Insights and Ideas

  • A "Cloned" HSA21q: The creation of the HSA21q-MAC represents a significant achievement in engineering a nearly complete, functional copy of a human chromosome arm within a mouse genome.
  • Non-Mosaicism is Key: Eliminating mosaicism is crucial for creating a reliable model. The TcMAC21 model achieves this, ensuring consistent genetic makeup across all cells, which is vital for reproducible research.
  • High Gene Content: The TcMAC21 model successfully incorporates 93% of HSA21q protein-coding genes (PCGs) and 79% of non-PCGs, making it the most comprehensive genetic representation of HSA21q in a mouse model to date.
  • Dosage Imbalance Drives Phenotypes: The study demonstrates that the extra copy of HSA21q leads to altered gene expression (dosage imbalance) and recapitulates many key DS phenotypes, from molecular pathologies to complex behavioral deficits.
  • Beyond Gene Content: The research highlights that simply having the genes isn't enough; their expression and regulation within the mouse genome are critical for observing relevant phenotypes.

Key Results

  • Successful Construction: The authors successfully created the TcMAC21 mouse model, confirmed by FISH and G-banding, showing a freely segregating HSA21q-MAC.
  • High Gene Representation: The HSA21q-MAC contains 93% of HSA21q PCGs and 79% of non-PCGs, with most genes being expressed and regulatable.
  • Non-Mosaic: TcMAC21 mice showed no evidence of mosaicism in various tissues and cell types, with retention rates of the HSA21q-MAC consistently above 92%.
  • DS Phenotypes Recapitulated: TcMAC21 mice exhibited a range of DS-like phenotypes, including:
  • Congenital Heart Defects (CHD): 28.6% of TcMAC21 mice showed structural heart defects.
  • Brain Abnormalities: Enlarged lateral ventricles and superior colliculus, and a smaller cerebellum were observed.
  • Craniofacial Differences: Differences in snout shape and neurocranium were detected.
  • Molecular/Cellular Pathologies: Elevated APP protein levels, increased Aβ40 and Aβ42, and increased chromosomal aberrations were noted.
  • Learning and Memory Deficits: TcMAC21 mice showed significant impairments in MWM, RRWM, and LTP, indicating deficits in learning, memory, and synaptic plasticity.
  • Growth Retardation: TcMAC21 mice were consistently smaller than their euploid littermates, showing about a 25% reduction in body weight at 90 days.

Limitations and Future Work

  • Human Genes in a Mouse Genome: While the model is highly comprehensive, some HSA21 genes lack mouse orthologs. The authors acknowledge that human genes may not function identically in a mouse genome, and stoichiometric differences are expected. However, they propose that the dosage imbalance of orthologous genes is likely to affect similar molecular, cellular, and developmental processes.
  • Further Validation: While extensive, the authors suggest that this model has potential for supporting a wide range of basic and preclinical research, implying ongoing and future studies will further validate its utility.
  • Comparison to Other Models: The paper includes a detailed comparison with other DS mouse models (Tc1, Ts65Dn, etc.), highlighting TcMAC21's advantages in terms of genetic completeness and lack of mosaicism.
  • Future Research: The authors envision TcMAC21 as a valuable tool for investigating the complex genetic basis of DS, exploring gene interactions, and testing therapeutic interventions for the diverse range of DS phenotypes.

Summary updated

Abstract

Animal models of Down syndrome (DS), trisomic for human chromosome 21 (HSA21) genes or orthologs, provide insights into better understanding and treatment options. The only existing transchromosomic (Tc) mouse DS model, Tc1, carries a HSA21 with over 50 protein coding genes (PCGs) disrupted. Tc1 is mosaic, compromising interpretation of results. Here, we "clone" the 34 MB long arm of HSA21 (HSA21q) as a mouse artificial chromosome (MAC). Through multiple steps of microcell-mediated chromosome transfer, we created a new Tc DS mouse model, Tc(HSA21q;MAC)1Yakaz ("TcMAC21"). TcMAC21 is not mosaic and contains 93% of HSA21q PCGs that are expressed and regulatable. TcMAC21 recapitulates many DS phenotypes including anomalies in heart, craniofacial skeleton and brain, molecular/cellular pathologies, and impairments in learning, memory and synaptic plasticity. TcMAC21 is the most complete genetic mouse model of DS extant and has potential for supporting a wide range of basic and preclinical research.
BibTeX
@inproceedings{kazuki2020non,
  author = {Yasuhiro Kazuki and Feng Gao and Yicong Li and Anna J. Moyer and Benjamin Devenney and Kei Hiramatsu and Sachiko Miyagawa‐Tomita and Satoshi Abe and Kanako Kazuki and Naoyo Kajitani and Narumi Uno and Shoko Takehara and Masato Takiguchi and Miho Yamakawa and Atsushi Hasegawa and Ritsuko Shimizu and Satoko Matsukura and Naohiro Noda and Narumi Ogonuki and Kimiko Inoue and Shogo Matoba and Atsuo Ogura and Liliana Florea and Alena Savonenko and Mei-Fang Xiao and Dan Wu and Denise Batista and Junhua Yang and Zhaozhu Qiu and Nandini Singh and Joan T. Richtsmeier and Takashi Takeuchi and Mitsuo Oshimura and Roger H. Reeves},
  title = {{A non-mosaic transchromosomic mouse model of Down syndrome carrying the long arm of human chromosome 21}},
  booktitle = {eLife},
  year = {2020},
  doi = {10.7554/elife.56223},
}
Figure